AU6022999A - Inhibiting cardiomyocyte death - Google Patents

Inhibiting cardiomyocyte death

Info

Publication number
AU6022999A
AU6022999A AU60229/99A AU6022999A AU6022999A AU 6022999 A AU6022999 A AU 6022999A AU 60229/99 A AU60229/99 A AU 60229/99A AU 6022999 A AU6022999 A AU 6022999A AU 6022999 A AU6022999 A AU 6022999A
Authority
AU
Australia
Prior art keywords
cardiomyocyte death
inhibiting cardiomyocyte
inhibiting
death
cardiomyocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60229/99A
Inventor
Mu-En Lee
Mark A Perrella
Shaw-Fang Yet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
MU EN LEE
SHAW FANG YET
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MU EN LEE, SHAW FANG YET, Harvard College filed Critical MU EN LEE
Publication of AU6022999A publication Critical patent/AU6022999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/99—Miscellaneous (1.14.99)
    • C12Y114/99003—Heme oxygenase (1.14.99.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU60229/99A 1998-08-28 1999-08-27 Inhibiting cardiomyocyte death Abandoned AU6022999A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9837798P 1998-08-28 1998-08-28
US60098377 1998-08-28
US12194699P 1999-02-25 1999-02-25
US60121946 1999-02-25
PCT/US1999/019823 WO2000012118A2 (en) 1998-08-28 1999-08-27 Inhibiting cardiomyocyte death

Publications (1)

Publication Number Publication Date
AU6022999A true AU6022999A (en) 2000-03-21

Family

ID=26794688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60229/99A Abandoned AU6022999A (en) 1998-08-28 1999-08-27 Inhibiting cardiomyocyte death

Country Status (2)

Country Link
AU (1) AU6022999A (en)
WO (1) WO2000012118A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2355066A1 (en) * 1998-12-17 2000-06-22 Sangstat Medical Corporation Extending graft survival by heme oxygenase-i expression induced immunomodulation
US20030022870A1 (en) * 2001-06-01 2003-01-30 Victor Dzau Methods of treating cardiac disorders
FR2842738B1 (en) * 2002-07-23 2006-02-10 Negma Lerads USE OF A RHEINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CHRONIC INFLAMMATION, THE PREVENTION AND TREATMENT OF REJECTION OF ORGAN AND TISSUE TRANSPLANTATION
CN105288599A (en) * 2015-10-22 2016-02-03 徐州医学院 Application of heme oxygenase-2 in preparing preparations inhibiting organ transplantation immune rejection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888982A (en) * 1996-04-01 1999-03-30 President And Fellows Of Harvard College Regulation of vascular smooth muscle cell heme oxygenase-1
US6057367A (en) * 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses

Also Published As

Publication number Publication date
WO2000012118A2 (en) 2000-03-09
WO2000012118A3 (en) 2000-06-29
WO2000012118A9 (en) 2000-09-28
WO2000012118A8 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU3255099A (en) Automated assembly line
AU9392998A (en) Pack-a-pillow
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AU5407599A (en) Sphingolipid-desaturase
AU3253699A (en) Myxochelines
AU8363398A (en) Capotasto
AU6022999A (en) Inhibiting cardiomyocyte death
AU2609599A (en) Sensor-coupling
AU2069199A (en) Codelets
AU3204999A (en) Futureball
AU1055399A (en) Rollerboard
EP0953510A3 (en) Case
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU5223199A (en) Bathtub-bathseat
AU751001C (en) Automated biogenerator
AU2840799A (en) 1-phosphanorbornadienes
AU3819799A (en) Methoximinomethyloxathiazines
AU6353599A (en) Compound
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover
AU9218098A (en) Exocyclic-phosphoethanolamines
AUPP350298A0 (en) Giddy up

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase